AKT1 and Insulin resistance: Intriguingly, these compounds exhibit hypoglycemic potential: Eriodictyol enhances glucose uptake and ameliorates insulin resistance via PI3K/AKT-mediated AKT phosphorylation [16] and stimulates insulin secretion through the cAMP/PKA pathway [17].